Work

Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 Infection

Year: 2009

Type: article

Source: The Journal of Infectious Diseases

DOI: 10.1086/597384

Authors: Jay H. Hoofnagle, Abdus S. Wahed, Robert S. Brown, Jr., Charles D. Howell, Steven H. Belle, Virahep‐C Study Group

Institutions: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NewYork–Presbyterian Hospital, University of Maryland, Baltimore, University of Pittsburgh

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources

Awards: Hepatitis C: host determinants of progression and respo*, G1185026198, G1235504160, Differential cytokine responses in Hep C patients., Interferon Resistance in Genotype 1 HCV, G190345214, G1963941650, Race &Viral Resistance in Chronic Hepatitis C (VIRAHEP*, G2290919401, G2318911837, G2448818300, Response of HCV to Therapy in African Americans, G2721354581, Hepatitis C Antiviral Resistance in African Americans, G3083420362, General Clinical Research Center, G3537622106, Study of Viral Resistance to Antiviral Therapy of Chron*, G3930031569, G395326895, G400718735, VIRAHEP-C Clinical Center, General Clinical Research Center, G451209962, HCV TREATMENT IN AFRICAN AMERICANS VS NON HISPANIC WHIT*, G5735069341, Antiviral Therapy in African Americans with HCV, Baltimore VIRAHEP-C Clinical Center, Cellular Immune Mechanisms of Resistance to HCV Therapy, G82803878, General Clinical Research Center, Resistance to Antiviral Therapy in Chronic Hepatitis C, GENERAL CLINICAL RESEARCH CENTER, G936736366

OpenAlex ID: W2098492088

FWCI: 6.186

Cites: 29

Cited by: 48

Related to: 10